Novavax (NVAX) closed the most recent trading day at $11.09, moving -1.25% from the previous trading session.
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.